Watson Pharmaceuticals (WPI) Tops Q3 EPS by 4c; Updates FY11 Outlook
Tweet
Share
E-mailGet Alerts WPI Hot Sheet
Join SI Premium – FREE
Watson Pharmaceuticals, Inc. (NYSE: WPI) reported Q3 EPS of $1.09, $0.04 better than the analyst estimate of $1.05. Revenue for the quarter came in at $1.08 billion versus the consensus estimate of $1.09 billion.
Watson Pharmaceuticals, Inc. sees FY2011 EPS of $4.55-$4.65, versus the consensus of $4.48. Watson Pharmaceuticals, Inc. sees FY2011 revenue of $4.5 billion, versus the consensus of $4.50 billion.
Watson Pharmaceuticals, Inc. sees FY2011 EPS of $4.55-$4.65, versus the consensus of $4.48. Watson Pharmaceuticals, Inc. sees FY2011 revenue of $4.5 billion, versus the consensus of $4.50 billion.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- North American Construction (NOA) Tops Q2 EPS by 9c; Offers Guidance
- Aptera Motors (SEV) Reports Q2 Loss of $0.20
- Southland Holdings (SLND) Misses Q2 EPS by 122c
Create E-mail Alert Related Categories
Earnings, GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
